scientist-testing-chemical-medical-research-digital-remix.jpg

ABOUT US

ATLyphe is a preclinical biotechnology spin-off from the ETH Zurich and University of Zurich.

Co-Founder, CSO

Renier Myburgh, PhD

With a PhD in molecular biology and a track record of co-founding two successful startups, he is a dedicated scientist driven to develop novel therapies from biological discoveries.

Button

Chief Development Officer

Lorenz Vogt, PhD

With >20y of experience in biotech, he is using his expertise in CMC development and general management to bring ALY117 into the clinics.

Button

Clinical Trial Manager

Marta Paolucci, PhD

With a PhD in allergology, she is leveraging her scientific expertise to establish rigorous clinical protocols and provide comprehensive support for trials

Button

ADVISORS

Clinical and Scientific Advisor

Prof. Dr. Markus G. Manz

Prof. Markus G. Manz is department chair for medical oncology & hematology at USZ, chair of the Comprehensive Cancer Center Zürich and full Professor of Hematology at the University of Zurich...

Learn more

Web

Scientific and Business Advisor

Prof. Dario Neri

Prof. Dario Neri was a full Professor of Biomacromolecules at ETH Zürich. He was trained as a chemist under Nobel laureate Kurt Wüthrich at ETH and performed a postdoc under Nobel laureate...

Learn more

Web

Business Advisor

Dr. Claudine Blaser

Dr. Claudine Blaser is Managing Director of Medgate Switzerland. She studied natural sciences at the ETH Zurich, obtained her doctorate in immunology and completed an ETH master's degree...

Learn more

ABOUT US

ATLyphe is a preclinical biotechnology spin-off from the ETH Zurich and University of Zurich.

ADVISORS

Inquiries

Head Office

Contact Us

Employment